Pfizer Inc PE Ratio (TTM) & PE Ratio (TTM) Charts - PFE

Current and historical daily PE Ratio for PFE ( Pfizer Inc ) from 1990 to Jul 21 2026. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Pfizer stock (PFE) PE ratio as of Jul 21 2026 is 19.04. More Details

Pfizer Inc (PFE) PE Ratio (TTM) Chart

Pfizer Inc (PFE) PE Ratio (TTM) Historical Data

View and export this data going back to 1990. Start your Free Trial

Total 1207

Pfizer PE Ratio (TTM) Historical Data
Date	PE Ratio (TTM) Data	Date	PE Ratio (TTM) Data
2026-07-21	18.9	19.09	18.81	19.04	2026-05-14	19.9	19.92	19.63	19.66
2026-07-20	19.1	19.2	18.87	18.89	2026-05-13	19.7	19.92	19.57	19.82
2026-07-17	19.4	19.58	19.06	19.12	2026-05-12	19.7	19.92	19.65	19.75
2026-07-16	19.0	19.36	18.97	19.19	2026-05-11	19.7	19.98	19.6	19.7
2026-07-15	18.6	18.95	18.56	18.95	2026-05-08	20.0	20	19.54	19.6
2026-07-14	18.6	18.65	18.42	18.51	2026-05-07	20.2	20.4	19.97	20.21
2026-07-13	18.5	18.87	18.5	18.69	2026-05-06	20.3	20.37	20.01	20.25
2026-07-10	18.6	18.63	18.39	18.45	2026-05-05	20.3	20.42	19.85	20.19
2026-07-09	18.4	18.55	18.33	18.51	2026-05-04	20.0	20.24	19.96	20.08
2026-07-08	18.4	18.6	18.24	18.36	2026-05-01	20.3	20.31	20.07	20.1
2026-07-07	18.4	18.59	18.27	18.37	2026-04-30	20.1	20.54	20.06	20.38
2026-07-06	18.4	18.47	18.03	18.11	2026-04-29	20.1	20.27	20	20.05
2026-07-02	18.4	18.76	18.42	18.56	2026-04-28	21.0	21.05	20.09	20.21
2026-07-01	18.4	18.5	18.12	18.23	2026-04-27	20.6	20.87	20.45	20.45
2026-06-30	18.6	18.67	18.15	18.38	2026-04-24	20.4	20.84	20.29	20.61
2026-06-29	18.5	18.7	18.4	18.6	2026-04-23	20.4	20.48	20.14	20.36
2026-06-26	18.1	18.59	18.12	18.54	2026-04-22	20.9	20.91	20.41	20.46
2026-06-25	18.5	18.58	18.03	18.07	2026-04-21	21.0	21.08	20.76	20.85
2026-06-24	18.9	19.17	18.26	18.35	2026-04-20	21.1	21.26	21	21.01
2026-06-23	19.1	19.26	18.85	18.87	2026-04-17	20.9	21.12	20.7	21.04
2026-06-22	19.3	19.32	19.05	19.15	2026-04-16	20.8	20.98	20.73	20.78
2026-06-18	19.5	19.59	19.04	19.24	2026-04-15	20.8	20.89	20.59	20.76
2026-06-17	19.9	20.06	19.74	19.79	2026-04-14	20.8	20.85	20.67	20.69
2026-06-16	19.9	19.95	19.62	19.88	2026-04-13	20.5	21.05	20.37	20.87
2026-06-15	20.0	20.17	19.83	19.85	2026-04-10	20.9	20.89	20.44	20.55
2026-06-12	20.1	20.22	19.93	20.01	2026-04-09	20.8	20.99	20.75	20.78
2026-06-11	19.7	20.21	19.69	19.98	2026-04-08	20.8	20.98	20.58	20.97
2026-06-10	19.7	19.73	19.53	19.54	2026-04-07	21.1	21.13	20.44	20.69
2026-06-09	19.6	19.76	19.44	19.62	2026-04-06	21.5	21.55	21.23	21.24
2026-06-08	19.8	20.01	19.54	19.56	2026-04-02	21.8	21.94	21.54	21.62
2026-06-05	19.7	20.01	19.69	19.88	2026-04-01	21.6	21.86	21.4	21.79
2026-06-04	19.6	19.85	19.55	19.61	2026-03-31	21.4	21.61	21.21	21.44
2026-06-03	19.4	19.56	19.31	19.34	2026-03-30	20.9	21.24	20.73	21.2
2026-06-02	19.5	19.62	19.29	19.5	2026-03-27	20.4	20.42	19.87	19.88
2026-06-01	19.8	19.78	19.45	19.56	2026-03-26	20.0	20.44	20.03	20.27
2026-05-29	20.0	20.03	19.79	19.98	2026-03-25	20.0	20.24	19.88	20.06
2026-05-28	20.0	20.06	19.85	19.95	2026-03-24	19.6	19.95	19.44	19.82
2026-05-27	19.7	20.26	19.73	20.01	2026-03-23	19.9	19.99	19.58	19.68
2026-05-26	19.8	19.77	19.59	19.73	2026-03-20	20.1	20.26	19.71	19.83
2026-05-22	19.9	19.96	19.66	19.77	2026-03-19	20.1	20.39	20.04	20.15
2026-05-21	19.7	19.82	19.52	19.81	2026-03-18	20.0	20.13	19.73	20.09
2026-05-20	19.7	19.87	19.6	19.69	2026-03-17	19.7	20.41	19.72	20.18
2026-05-19	19.3	19.82	19.27	19.59	2026-03-16	19.6	19.77	19.5	19.57
2026-05-18	19.3	19.38	19.23	19.34	2026-03-13	19.9	20.06	19.54	19.54
2026-05-15	19.7	19.72	19.27	19.34	2026-03-12	19.9	19.94	19.58	19.75

Pfizer Inc (PFE) PE Ratio (TTM) Comparison

Company	Market Cap(Mil)	PE Ratio (TTM)

Business Description

Pfizer Inc

NAICS : 325412 SIC : 2834
ISIN : US7170811035

https://www.pfizer.com

66 Hudson Boulevard East, New York, NY, USA, 10001-2192

Share Class Description:

PFE: Ordinary Shares

Total Employee Number:

75,000

Compare

GILDBMYAMGNBIIBOGNAMRNSCLXMIRANSRXMDCXLLYJNJABBVXSWX:ROPMRKXSWX:NOVNLSE:AZNOCSE:NOVO BLSE:GSKXPAR:SAN

Traded in other countries / regions

PFE.USAPFE.Canada0Q1N.UKPFE.GermanyPFE.ArgentinaPFE.MexicoPFIZ34.Brazil1PFE.ItalyPFE.AustriaPFE_KZ.KazakhstanPFE.SwitzerlandPFE.PeruPFE.BulgariaPFE.ChilePFECO.ColombiaPFE.Ukraine

Index Membership

S&P 500 Russell 1000 Russell 3000 MSCI World Index Dow 30

IPO Date

1951-06-22

Description

Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.